
================================================================================
CANCER EVOLUTION PROJECT: COMPREHENSIVE ANALYSIS REPORT
================================================================================

PROJECT: Phylogenetic Analysis of Breast Cancer Subclones
DATE: 2026-01-30 14:44:09
ANALYST: Cancer Evolution Research

================================================================================
1. DATASET OVERVIEW
================================================================================
Total cells in analysis: 1,508
Total genes profiled: 20,814
Cancer subclones identified: 7

Original cancer clusters:
  • Cluster 1 (Luminal Epithelial): 556 cells
  • Cluster 2 (Luminal Epithelial): 535 cells
  • Cluster 4 (Basal/Myoepithelial): 417 cells

================================================================================
2. SUBCLONE DISTRIBUTION & CHARACTERISTICS
================================================================================

Subclone 0:
  Population:  336 cells ( 22.3%)
  Origin: Cluster 1
  Spatial compactness: 1.51

Subclone 1:
  Population:  283 cells ( 18.8%)
  Origin: Cluster 2
  Spatial compactness: 1.40

Subclone 2:
  Population:  269 cells ( 17.8%)
  Origin: Cluster 4
  Spatial compactness: 1.61

Subclone 3:
  Population:  251 cells ( 16.6%)
  Origin: Cluster 2
  Spatial compactness: 1.24

Subclone 4:
  Population:  152 cells ( 10.1%)
  Origin: Cluster 4
  Spatial compactness: 1.05

Subclone 5:
  Population:  113 cells (  7.5%)
  Origin: Cluster 1
  Spatial compactness: 0.93

Subclone 6:
  Population:  104 cells (  6.9%)
  Origin: Cluster 1
  Spatial compactness: 1.22

================================================================================
3. EVOLUTIONARY RELATIONSHIPS
================================================================================

PHYLOGENETIC TREE INSIGHTS:
- Tree depth (maximum divergence): 33.29
- Median pairwise distance: 1.20

Closest subclone pairs (most recent common ancestor):
  • SC1 ↔ SC3: distance = 15.83, 314 DE genes
  • SC0 ↔ SC5: distance = 17.43, 416 DE genes
  • SC5 ↔ SC6: distance = 18.07, 99 DE genes
  • SC0 ↔ SC6: distance = 19.74, 793 DE genes
  • SC2 ↔ SC4: distance = 21.67, 814 DE genes

Most diverged subclone pairs:
  • SC1 ↔ SC4: distance = 33.06, 2587 DE genes
  • SC1 ↔ SC2: distance = 33.43, 3577 DE genes
  • SC3 ↔ SC6: distance = 35.36, 2767 DE genes
  • SC1 ↔ SC5: distance = 36.46, 3133 DE genes
  • SC1 ↔ SC6: distance = 40.03, 3983 DE genes

================================================================================
4. FUNCTIONAL PATHWAY ANALYSIS
================================================================================

PATHWAY EXPRESSION HIGHLIGHTS:

Highest Cell Cycle Activity:
  • SC6: 0.537
  • SC0: 0.409

Highest EMT/Metastasis (Aggressive Phenotype):
  • SC6: EMT=0.255, Metastasis=0.474
  • SC4: EMT=0.137, Metastasis=0.158

Highest ECM Remodeling:
  • SC6: 1.196
  • SC4: 0.656

Unique Immune Response:
  • SC3: 0.512 (only positive subclone)

================================================================================
5. SPATIAL DISTRIBUTION
================================================================================

Most compact subclones (tight clustering):
  • SC5: compactness = 0.93
  • SC4: compactness = 1.05
  • SC6: compactness = 1.22

Most dispersed subclones:
  • SC1: compactness = 1.40
  • SC0: compactness = 1.51
  • SC2: compactness = 1.61

Spatially proximate pairs (potentially sharing niches):
  • SC5 ↔ SC6: distance = 1.88
  • SC5 ↔ SC0: distance = 3.02
  • SC1 ↔ SC3: distance = 3.38

================================================================================
6. EVOLUTIONARY RATES & DIVERGENCE
================================================================================

Correlation between genetic distance and transcriptional divergence:
  • Pearson r = 0.931 (very strong correlation)
  • p-value < 0.001 (highly significant)

Most evolutionarily divergent subclone:
  • SC1: Average 2692 DE genes vs other subclones

Most conserved subclone:
  • SC5: Average 1306 DE genes vs other subclones

Fastest evolving pairs:
  • SC1-SC6: 3983 DE genes
  • SC1-SC2: 3577 DE genes
  • SC1-SC5: 3133 DE genes
  • SC2-SC3: 2776 DE genes
  • SC3-SC6: 2767 DE genes

================================================================================
7. BIOLOGICAL INTERPRETATION
================================================================================

EVOLUTIONARY MODEL:
The analysis reveals a complex evolutionary landscape with 7 distinct cancer 
subclones showing varying degrees of divergence. The strong correlation between
genetic distance and transcriptional divergence (r=0.931) suggests consistent
evolutionary processes.

KEY FINDINGS:

1. SUBCLONE DIVERSITY:
   • Both luminal (SC0,1,3,5,6) and basal (SC2,4) lineages show intra-subtype
     heterogeneity, indicating ongoing evolution within cell types

2. EVOLUTIONARY HOTSPOTS:
   • SC1 shows highest average divergence, suggesting it may represent a
     rapidly evolving or early-branching lineage
   • SC5 and SC6 are extremely similar (99 DE genes), likely sister clones
     from recent common ancestor

3. FUNCTIONAL DIVERSIFICATION:
   • SC6 shows aggressive phenotype: high EMT, metastasis, and ECM remodeling
   • SC3 unique immune signature may represent immunogenic subclone
   • SC0,5 show proliferative luminal phenotype with lower aggression markers

4. SPATIAL ORGANIZATION:
   • Compact subclones (SC5, SC4) suggest niche-specific adaptation
   • Dispersed subclones (SC2) may occupy multiple microenvironments
   • Spatial proximity of SC5-SC6 consistent with their genetic similarity

5. THERAPEUTIC IMPLICATIONS:
   • Heterogeneity suggests multi-targeted therapy may be necessary
   • SC6's aggressive profile makes it priority therapeutic target
   • SC3's immune signature may be amenable to immunotherapy

================================================================================
8. OUTPUT FILES GENERATED
================================================================================

✓ VISUALIZATIONS:
  • cancer_cells_identification.png
  • final_subclones_selected.png
  • genetic_distance_matrix.png
  • phylogenetic_tree.png
  • comprehensive_evolutionary_map.png
  • subclone_driver_genes_heatmap.png
  • subclone_markers_dotplot.png
  • pathway_heatmap_comprehensive.png
  • pathway_dotplot_summary.png
  • spatial_distribution_subclones.png
  • subclone_density_maps.png
  • spatial_overlap_analysis.png
  • evolutionary_rate_analysis.png

✓ DATA FILES:
  • driver_genes_subclone_*.csv (marker genes for each subclone)
  • genes_for_enrichment_SC*.txt (for external pathway analysis)
  • pairwise_de_gene_counts.csv (evolutionary divergence data)
  • cluster_markers.csv
  • cell_type_summary.csv

================================================================================
9. RECOMMENDATIONS FOR FUTURE ANALYSIS
================================================================================

1. Copy Number Variation Analysis:
   • Use inferCNV or copyKAT to identify CNV-based subclones
   • Compare CNV-based vs expression-based phylogeny

2. Trajectory Analysis:
   • Perform RNA velocity analysis to infer directionality
   • Use CellRank or scVelo for dynamic trajectory inference

3. External Pathway Enrichment:
   • Upload gene lists to Enrichr/g:Profiler for comprehensive pathways
   • Perform Gene Set Enrichment Analysis (GSEA)

4. Clinical Correlation:
   • If available, correlate subclones with patient outcomes
   • Assess subclone signatures in independent cohorts

5. Multi-omics Integration:
   • Integrate with ATAC-seq, proteomics if available
   • Spatial transcriptomics to validate spatial organization

================================================================================
END OF COMPREHENSIVE ANALYSIS REPORT
================================================================================
